References
1. Suzuki E, Nakai D, Ikenaga H et al. In vivo inhibition of acylpeptide
hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs. Xenobiotica.
2016;46:126-31.
2. Ishikawa T, Otaki H, Mizuta S et al. Computational
study of the competitive binding of valproic acid glucuronide and carbapenem
antibiotics to acylpeptide hydrolase. Drug
Metab Pharmacokinet.
2017;32:201-7.
3. Wu CC, Pai TT, Hsiao FY et al. The effect of
different carbapenem antibiotics (ertapenem, imipenem/cilastatin, and
meropenem) on serum valproic acid concentrations.
Ther Drug Monit.
2016;38:587-92.
4. Wen Z-P, Fan S-S, Du C et al. Drug-drug interaction
between valproic acid and meropenem: a retrospective analysis of electronic
medical records from neurosurgery inpatients. J Clin Pharm Ther. 2017;42:221-7.
5. Velez-Diaz-Pallares M, Silveira ED, Diaz AM, et al. Analysis of the valproic acid-meropenem
interaction in hospitalized patients. Neurologia. 2012;27:34-8.
6. Haroutiunian S, Ratz Y, Rabinovich B et al. Valproic
acid plasma concentration decreases in
a dose-independent manner following administration of meropenem: a
retrospective study. J Clin Pharmacol.
2009;49:1363-9.
7. Huang CR, Lin CH, Hsiao
SC et al. Drug interaction between valproic acid and carbapenems in patients
with epileptic seizures. Kaohsiung J Med
Sci. 2017;33:130-6.
8. Herrero MCM, Romero AJA, Vilaplana VE et al. Pharmacological interaction between valproic
acid and carbapenem: what about levels in pediatrics? Eur J Paediat Neurol. 2015;19:155-61.
9. Doribax [package insert].
Osaka, Japan; Shinogi Inc., 2015.
10. Masuo
Y, Ito K, Yamamoto T et al. Characterization of inhibitory effect of carbapenem
antibiotics on the deconjugation of valproic acid glucuronide. Drug Metab Dispos. 2010;38:1828-35.